We've found
2,763
archived clinical trials in
Colitis
We've found
2,763
archived clinical trials in
Colitis
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Updated: 8/1/2016
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Updated: 8/1/2016
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitis
Updated: 8/1/2016
A Phase I, Multicenter, Randomized, Placebo-Controlled, Double-Blind Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Intravenous and Subcutaneous rhuMAb Beta7 Administered in a Single-Dose, Dose-Escalation Stage Followed by a Multidose, Parallel-Treatment Stage in Patients With Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
A Study Of Oral CP-690,550 As A Maintenance Therapy For Ulcerative Colitis
Updated: 8/11/2016
A Multicentre, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study Of Oral CP-690,550 As A Maintenance Therapy In Subjects With Ulcerative Colitis
Status: Enrolling
Updated: 8/11/2016
Click here to add this to my saved trials